AI Designs Novel Vaccine for Future Pandemics

London. Scientists have developed a new type of vaccine using artificial intelligence (AI), which is believed to be able to prevent future pandemics and provide broad protection against various types of viruses. According to researchers at Cambridge University, this is the world's first attempt to design the main component of a vaccine entirely by AI and test it on humans.

This vaccine has been developed with the aim of being effective against all types of viruses in the coronavirus family. It is expected to provide protection not only against various variants of COVID-19 but also against potential new coronaviruses that can spread from animals to humans.

According to Jonathan Heeney, the lead scientist of the research team, many currently used vaccines need to be updated from time to time to combat new forms of the virus. However, he said that the new technology aims to provide protection by targeting viruses that may appear in the future. According to him, scientists provided various genetic information of coronaviruses to the AI system for analysis. The AI then designed a special component called 'super antigen', which can train the immune system to respond against the entire family of viruses.

The initial trial of the vaccine was conducted on 39 people. The main objective of the trial was to evaluate its safety. Another study is currently ongoing with approximately 200 participants, which will clarify how effectively the vaccine activates the immune system. The research results have been published in the Journal of Infection. Although the initial results showed a moderate immune response, it has generated great enthusiasm in the scientific community.

Professor Saul Faust of the University of Southampton has stated that the technology of designing vaccines through AI has great potential. According to him, such technology can be particularly useful for situations where viruses are constantly changing. The research team has also stated that they are currently working on universal flu vaccines that do not require annual modification, vaccines against bird flu (H5N1), and vaccines against deadly viruses like Ebola.

Andy Pollard, director of Oxford Vaccine Group, has also said that AI can become a 'game changer' in vaccine research in the future. According to him, the vaccine development process will become faster and more effective as AI can predict how the immune system will respond to a vaccine. Experts say that if this technology is successful, it may be possible to develop vaccines that provide protection against pandemics before they start, which is expected to usher in a new era in global health.